African kingdom has accepted 15 men as part of a third-country deportation program. This program, which has been strongly ...
Zacks Investment Research on MSN
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal
Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for ...
Gilead Sciences Inc.’s stock GILD jumped 4.5% early Thursday after the company said its experimental twice-yearly injection for HIV prevention was found 100% effective in a late-stage trial. The ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
The United States has begun distributing a groundbreaking HIV-prevention treatment to two African nations, marking a ...
The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...
The Gauteng Department of Health has strengthened its STI prevention strategy through targeted screening, outreach, and HIV ...
Palm Beach County is hosting a World AIDS Day luncheon and panel on December 1, 2025, to discuss HIV care advancements.
Burlington Free Press on MSN
UVM joins major study on drug use and treatment barriers across New England
The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...
If the preference for absolute freedom over the free person is a fact of the sexual revolution, the present time is as much at the height of this phenomenon as the 1960s was. However, today, we can’t ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback